Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Outcomes and Safety of Niraparib as Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, Ovarian Cancer. The First Real-World Evidence Study From Poland.

NCT06614790 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.

NCT NCT06614790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06614790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Outcomes and Safety of Niraparib as Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, Ovarian Cancer. The First Real-World Evidence Study From Poland.
Lead sponsor
Pomeranian Medical University Szczecin
Phase
Observational
Overall status
Recruiting
Start date
September 2, 2024
Completion date
January 7, 2026
Enrollment
300 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer